###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 69 73 <span type="species:ncbi:10090">Mice</span>
###xml 78 84 <span type="species:ncbi:9606">Humans</span>
VAV2 and VAV3 as Candidate Disease Genes for Spontaneous Glaucoma in Mice and Humans
###end article-title 0
###begin p 1
Conceived and designed the experiments: KF TI KI. Performed the experiments: KF TI MA HK MF QC. Analyzed the data: KF TI KI MA MF MW EMB WAS. Contributed reagents/materials/analysis tools: KF TI KI MW WAS. Wrote the paper: KF KI EMB WAS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Glaucoma is a leading cause of blindness worldwide. Nonetheless, the mechanism of its pathogenesis has not been well-elucidated, particularly at the molecular level, because of insufficient availability of experimental genetic animal models.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 724 728 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 733 737 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 560 565 <span type="species:ncbi:10090">mouse</span>
###xml 570 575 <span type="species:ncbi:9606">human</span>
###xml 805 813 <span type="species:ncbi:9606">patients</span>
Here we demonstrate that deficiency of Vav2 and Vav3, guanine nucleotides exchange factors for Rho guanosine triphosphatases, leads to an ocular phenotype similar to human glaucoma. Vav2/Vav3-deficient mice, and to a lesser degree Vav2-deficient mice, show early onset of iridocorneal angle changes and elevated intraocular pressure, with subsequent selective loss of retinal ganglion cells and optic nerve head cupping, which are the hallmarks of glaucoma. The expression of Vav2 and Vav3 tissues was demonstrated in the iridocorneal angle and retina in both mouse and human eyes. In addition, a genome-wide association study screening glaucoma susceptibility loci using single nucleotide polymorphisms analysis identified VAV2 and VAV3 as candidates for associated genes in Japanese open-angle glaucoma patients.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 59 65 <span type="species:ncbi:10090">murine</span>
###xml 186 192 <span type="species:ncbi:9606">humans</span>
Vav2/Vav3-deficient mice should serve not only as a useful murine model of spontaneous glaucoma, but may also provide a valuable tool in understanding of the pathogenesis of glaucoma in humans, particularly the determinants of altered aqueous outflow and subsequent elevated intraocular pressure.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Kass1">[1]</xref>
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-AGIS1">[2]</xref>
###xml 232 235 232 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Gabelt1">[3]</xref>
###xml 237 240 237 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Tan1">[4]</xref>
###xml 377 382 <span type="species:ncbi:10090">mouse</span>
The critical importance of elevated intraocular pressure (IOP) in the pathogenesis of glaucomatous optic neuropathy is widely recognized [1], [2]. While compromise of aqueous humor outflow is the key determinant of elevation in IOP [3], [4], the molecular mechanisms underlying changes in the outflow pathway that lead to elevated IOP remain to be elucidated. For this reason, mouse genetic knockout models of spontaneous glaucoma are highly sought after.
###end p 9
###begin p 10
###xml 190 193 190 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Bustelo1">[5]</xref>
###xml 436 439 436 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Schmidt1">[6]</xref>
###xml 857 860 857 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Bustelo1">[5]</xref>
###xml 862 865 862 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Turner1">[7]</xref>
###xml 973 980 973 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1143 1146 1143 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Swat1">[8]</xref>
###xml 1147 1151 1147 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Tybulewicz1">[16]</xref>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 1286 1291 <span type="species:ncbi:10090">mouse</span>
The Vav proteins are the best-characterized family of guanine nucleotide exchange factors (GEFs) that activates Rho guanosine triphosphatases (GTPases) in a phosphorylation-dependent manner [5]. Rho GTPases control cell behavior via regulating the specific filamentous actin structures involved in migration, adhesion, and morphogenesis, by acting as binary switches cycling between an inactive (GDP-bound) and active (GTP-bound) state [6]. The three mammalian Vav proteins, Vav1, Vav2, and Vav3, share a Dbl homology domain for their enzymatic activity as GEFs and contain a common structural array characteristic of proteins involved in signal transduction. Regardless of the structural similarity, Vav proteins differ in their tissue distribution. Vav1 is expressed specifically in lymphoid lineage cells, whereas Vav2 and Vav3 are more widely expressed [5], [7]. Genetic approaches using knockout mice have provided valuable information on the function of Vav proteins in vivo. Vav proteins are crucial for the development and function of hematopoietic lineage cells such as lymphocytes, neutrophils, natural killer cells, and osteoclasts [8]-[16]. Individual Vav proteins exhibit both redundant and specialized functions. Despite the wide distribution of Vav2 and Vav3 proteins in mouse tissues, little is known about their specific function in non-hematopoietic cells.
###end p 10
###begin p 11
###xml 662 666 662 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 671 675 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 800 808 <span type="species:ncbi:9606">patients</span>
While trying to better elucidate the functions of Vav2 and Vav3 in non-hematopoietic cells, we discovered that Vav2/Vav3-deficient mice have a significant ocular phenotype. Specifically, we show that Vav2/Vav3-deficient mice have elevated IOP, which eventually manifests as buphthalmos. Loss of Vav2 and Vav3 expression is associated with changes in the iridocorneal angle, with eventual chronic angle closure. The elevation of IOP in Vav2/Vav3-deficient mice is accompanied by an optic neuropathy characterized by selective loss of retinal ganglion cells (RGCs) and optic nerve head (ONH) excavation and is therefore consistent with glaucoma. In addition, both VAV2 and VAV3 are shown to be susceptibility loci by single nucleotide polymorphisms (SNPs) study of Japanese primary open-angle glaucoma patients.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 20 24 <span type="species:ncbi:10090">Mice</span>
Vav2/Vav3-Deficient Mice Develop Buphthalmos
###end title 13
###begin p 14
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 124 132 124 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g001">Figure 1</xref>
###xml 392 401 392 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g001">Figure 1A</xref>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 503 506 503 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 510 513 510 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 580 589 580 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g001">Figure 1B</xref>
###xml 675 678 675 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 682 685 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 671 685 671 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 759 768 759 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g001">Figure 1C</xref>
###xml 970 973 970 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 977 980 977 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 966 980 966 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 981 985 <span type="species:ncbi:10090">mice</span>
Eyes of Vav2/Vav3-deficient (Vav2-/-Vav3-/-) mice were noted to develop buphthalmos starting between 6 and 12 weeks of age (Figure 1). This enlargement was typically seen unilaterally at first, with frequent bilateral involvement over the next 1-2 months, and continued enlargement until the mice were 6-months old. Eventually, some of the eyes, became atrophic and phthisical in appearance (Figure 1A). In order to confirm our initial observations, we measured the corneal diameters and weights of Vav2-/-Vav3-/- mice eyes and compared them with age-matched wild-type mice eyes (Figure 1B). The examination clearly showed our observations were relevant. We observed 200 Vav2-/-Vav3-/- mice at 6 months of age and almost 75% of them showed the enlarged eyes (Figure 1C). In addition, histological study indicated that there were no abnormal findings in the tissues both around the enlarged eyes such as inflammation, tumor, or hyperplasia, and in the thyroid of the Vav2-/-Vav3-/- mice (data not shown).
###end p 14
###begin title 15
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Vav2/Vav3-deficient mice develop buphthalmos.
###end title 15
###begin p 16
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 29 43 29 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 179 193 179 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 277 291 277 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 380 394 380 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 401 402 401 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 642 645 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 649 652 645 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 638 652 634 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 825 829 817 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 829 832 821 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 832 836 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 836 839 828 831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 916 917 904 905 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 978 981 966 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 985 988 973 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 974 988 962 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 1057 1060 1045 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1064 1067 1052 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1053 1067 1041 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
###xml 1068 1072 <span type="species:ncbi:10090">mice</span>
Eyes of Vav2/Vav3-deficient (Vav2-/-Vav3-/-) mice develop buphthalmos between 6 and 12 weeks of age. A. Left photo: Representative photo of unilateral enlarged eye in 10-week-old Vav2-/-Vav3-/- mice. Centre photo: Representative photo of bilateral enlarged eyes in 16-week-old Vav2-/-Vav3-/- mice. Right photo: Representative photo of enlarged eye becoming atrophic in 8-week-old Vav2-/-Vav3-/- mice. B. Comparison of eye sizes. Left panel: Representative eye of 10-week-old wild-type (WT) mice as a control (n = 20). Cornea diameter is 2.9+/-0.1 mm. Weight is 15.8+/-1.1 mg. Centre panel: Representative first-recognized enlarged eye of Vav2-/-Vav3-/- mice (9- to 10-week-old, n = 20). The cornea diameter is 3.3+/-0.1 mm. Weight is 23.7+/-4.4 mg. P<0.001. Right panel: Representative moderately enlarged eye of 12-week-old Vav2-/-Vav3-/-mice (n = 20). The cornea diameter is 4.2+/-0.4 mm. Weight is 38.0+/-4.0 mg. C. Age of onset of enlarged eyes up to 25 weeks of age in Vav2-/-Vav3-/- mice (n = 200). The vertical axis is a cumulative percentage of Vav2-/-Vav3-/- mice with enlargement of the eyes.
###end p 16
###begin title 17
###xml 51 55 <span type="species:ncbi:10090">Mice</span>
Elevation of Intraocular Pressure of Vav-Deficient Mice
###end title 17
###begin p 18
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 389 392 389 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 396 399 396 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 385 399 385 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 562 571 554 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g002">Figure 2A</xref>
###xml 598 601 590 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 605 608 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 594 608 586 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 746 749 738 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 753 756 745 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 742 756 734 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 906 915 898 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009050.s001">Figure S1</xref>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
As we observed the development of buphthalmos, we assessed for elevated IOP in Vav2-/-Vav3-/-, Vav2-deficient (Vav2-/-), and Vav3-deficient (Vav3-/-) mice. IOP was measured using a rodent tonometer (Tonolab) starting at 4 weeks post-natal and were compared with age-matched wild-type C57BL/6 mice. Reliable measurement of IOP before 4 weeks of age was not possible. At 6 weeks of age, Vav2-/-Vav3-/- mice first showed increased IOP (18.2+/-3.1 vs. 14.0+/-2.4 mmHg, p<0.05), with further increases out to 10 weeks of age (22.5+/-7.4 vs. 14.6+/-4.2 mmHg, p<0.01) (Figure 2A). IOP measurements in Vav2-/-Vav3-/- mice ranged from 11-40 mmHg between 7 weeks and 16 weeks of age. There was a statistically significant difference in IOP between the Vav2-/-Vav3-/- and wild-type mice at all time points demonstrated. The phenotype of littermate wild type mice was identical to that of the "inbred" C57BL/6 strain (Figure S1).
###end p 18
###begin title 19
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 33 47 33 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup></italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Elevated intraocular pressure of Vav2-/-Vav3-/- and Vav2-/- mice.
###end title 19
###begin p 20
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 122 125 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 455 456 455 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 477 480 477 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 532 533 532 533 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 539 542 539 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 601 602 601 602 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 604 608 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 608 611 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
###xml 318 323 <span type="species:ncbi:10090">mouse</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
The intraocular pressure (IOP) of Vav2/Vav3-deficient (Vav2-/-Vav3-/-), Vav2-deficient (Vav2-/-), and Vav3-deficient (Vav3-/-) mice were measured between 10-12 AM. At the indicated ages, twenty mice were examined, respectively. For the IOP measurement of each Vav-deficient mouse, IOP of an age-matched wild-type (WT) mouse was also measured under the same conditions. We confirmed that these results were reproducible with four independent examinations. A. IOPs of Vav2-/-Vav3-/- mice were dramatically elevated at 6 weeks of age. B. Vav2-/- mice also showed elevated IOP from around 8 weeks of age. C. Vav3-/- mice have normal range of IOP at any age. Error bars represent S.D. *P<0.05, **P<0.01 versus WT mice.
###end p 20
###begin p 21
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 3 10 3 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup></italic>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup></italic>
###xml 205 214 201 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g002">Figure 2B</xref>
###xml 228 232 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 232 235 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 401 404 393 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 397 404 389 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 483 492 475 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g002">Figure 2C</xref>
###xml 675 679 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 679 682 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 688 692 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 692 695 684 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 729 738 721 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009050.s001">Figure S1</xref>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
In Vav2-/- mice, elevated IOP was first detected at 7 weeks of age. The IOP for Vav2-/- mice was found to be increased at 8 weeks of age compared to wild-type mice (15.5+/-3.7 vs. 14.0+/-4.2 mmHg, p<0.05)(Figure 2B). The IOP of Vav2-/- mice showed further increases at 10 weeks of age (18.1+/-3.7 vs. 14.6+/-4.2 mmHg, p<0.01) and remained significantly higher at 12 weeks. In contrast, the IOP of Vav3-/- mice did not differ significantly from wild-type mice between 8 and 12 weeks (Figure 2C). The phenotype of littermate wild type mice was identical to that of inbred strain "C57BL/6". We also demonstrated that the phenotype of Vav2 and Vav3 heterozygous littermate mice (Vav2+/-, and Vav3+/-) were same as that of wild type (Figure S1).
###end p 21
###begin title 22
###xml 79 83 <span type="species:ncbi:10090">Mice</span>
Retinal Ganglion Cell Loss and Optic Nerve Head Changes in Vav2/Vav3-Deficient Mice
###end title 22
###begin p 23
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 312 321 312 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g003">Figure 3A</xref>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 477 480 477 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 466 480 466 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 487 496 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g003">Figure 3B</xref>
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 530 533 530 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 537 540 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
We next examined whether Vav2/Vav3-deficient (Vav2-/-Vav3-/-) mice showed changes in the retinal ganglion cell (RGC) layer and optic nerve head (ONH). At 3 weeks of age, Vav2-/-Vav3-/- mice did not show any histological difference in the ONH or the number of RGCs compared to that of age-matched wild-type mice (Figure 3A). At 10 weeks of age, following several weeks of IOP elevation, early signs of ONH cupping and cell body loss in the RGC layer were apparent in Vav2-/-Vav3-/- mice (Figure 3B). At 15 and 30 weeks of age, Vav2-/-Vav3-/- mice showed further evidence of ONH cupping and RGC loss in the context of an otherwise normal retinal architecture. These findings are consistent with a selective loss of RGCs with corresponding changes in the ONH, which are the hallmarks of glaucoma.
###end p 23
###begin title 24
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 63 77 63 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Optic nerve head degeneration and decrease in RGCs observed in Vav2-/-Vav3-/- mice with elevated IOP.
###end title 24
###begin p 25
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 122 125 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 111 125 111 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 133 134 133 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 163 166 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 170 173 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 159 173 159 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 406 407 394 395 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 526 530 514 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 530 533 518 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 533 537 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 537 540 525 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
Light-microscopic histological examination is conducted to evaluate retinal neuropathy in Vav2/Vav3-deficient (Vav2-/-Vav3-/-) mice. A. At the age of 3 weeks, Vav2-/-Vav3-/- mice exhibited impairment of angle status, but no abnormal findings of Optic nerve head degeneration (ONH) or retinal ganglion cells (RGCs) in the retinas. Scale bars, from left to right side: 500 microm, 100 microm, and 50 microm. B. After elevation of IOP, compared to control wild-type (WT) mice in the upper panel, ONH in 10-, 15-, and 30-week-old Vav2-/-Vav3-/- mice present so-called capping (shown in c) and thin retinal neural layers (indicated by arrows in the photos). In those retinas, RGCs are decreased. Scale bars, from left to right side: 500 microm, 100 microm, and 50 microm. Sections are representative from 6-12 samples.
###end p 25
###begin title 26
###xml 51 55 <span type="species:ncbi:10090">Mice</span>
Iridocorneal Angle Histopathology in Vav-Deficient Mice
###end title 26
###begin p 27
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 185 188 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 192 195 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 506 515 506 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g004">Figure 4A</xref>
###xml 666 675 666 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g004">Figure 4B</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
As histopathological examination of globes from mice with buphthalmos frequently demonstrated angle closure, we compared the iridocorneal angle histology of 20 Vav2/Vav3-deficient (Vav2-/-Vav3-/-) mice with wild-type mice at both 7 and 12 weeks of age. Angles were classified as either being completely open, displaying evidence of partial occlusion of the trabecular meshwork (TM) as manifest by peripheral anterior synechiae (PAS), or being completely closed (total occlusion of the trabecular meshwork)(Figure 4A). Over half of the Vav2/Vav3-deficient mice already showed evidence of angle closure by 7 weeks of age, increasing to nearly 80% in 12-week-old mice (Figure 4B).
###end p 27
###begin title 28
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 63 74 63 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3</italic>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Characterization of progressive iridocorneal angle closures in Vav2-/-Vav3-/- and Vav2-/- mice.
###end title 28
###begin p 29
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 131 142 131 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3</italic>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 271 272 271 272 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 474 477 474 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 470 481 470 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3</italic>
###xml 481 484 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 535 538 535 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 531 542 531 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3</italic>
###xml 542 545 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 674 675 666 667 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 759 762 751 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 755 766 747 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3</italic>
###xml 766 769 758 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 771 775 763 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 775 778 767 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 784 788 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 788 791 780 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 945 948 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 952 955 944 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 941 960 933 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup> mice</italic>
###xml 995 998 987 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1002 1005 994 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 991 1010 983 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup> mice</italic>
###xml 1035 1039 1027 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 1039 1042 1031 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1042 1046 1034 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 1046 1049 1038 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1062 1066 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 1066 1069 1058 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1071 1075 1063 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 1075 1078 1067 1070 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
###xml 1006 1010 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
The aqueous humor outflow facility, trabecular meshwork (TM) and Schlemm's canal (SC) (iridocornial angle) in Vav2/Vav3-deficient (Vav2-/-Vav3-/-) mice are evaluated in histological manner. Vav2-deficient (Vav2-/-) mice also have the same changes, but of lower severity. A. Representative photos of normal TM and SC histology of 12-week-old wild-type (WT) mice as a control. Representative photos of normal open angle, peripheral anterior synechiae (PAS) in 12-week-old Vav2-/-Vav3-/- mice, and angle closure status in 12-week-old Vav2-/-Vav3-/- mice. Sections used here are all representative from 20 samples. Scale bars: left photos, 200 microm; right photos, 100 microm. B. Changes of angle status appear at the early ages. We classify angle status of Vav2-/-Vav3-/-, Vav2-/-, and Vav3-/-mice into open angle, PAS, and angle closure by histological evaluation. We find the changes of angle status at the early ages, such as in 18-day-old Vav2-/-Vav3-/- mice (n = 20) and in 4-week-old of Vav2-/-Vav3-/- mice (n = 20). We took four (Vav2-/-Vav3-/-) and three (Vav2-/-, Vav3-/-) different age groups, with 20 mice examined, respectively.
###end p 29
###begin p 30
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 97 100 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 129 138 129 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009050.s002">Figure S2</xref>
###xml 381 385 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 385 388 383 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 388 392 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 392 395 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 484 488 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 488 491 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 491 495 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 495 498 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
We also examined the correlation between elevated IOP and angle changes in 7-week-old Vav2-/-Vav3-/- mice respectively (n = 20) (Figure S2). The mean and standard deviation of IOP in 7-week-old wild-type mice (n = 18) were 13.7+/-3.12 mmHg respectively. The 95th percentile of those IOPs using a normal curve was 18.8 mmHg. So that IOP over 18.8 mmHg was regarded as elevated IOP. Vav2-/-Vav3-/- mice with elevated IOP showed evidence of angle closure by histological analysis, while Vav2-/-Vav3-/- mice with non-elevated IOP displayed either open angles or evidence of early angle closure (PAS) and angle closure.
###end p 30
###begin p 31
###xml 312 321 312 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g004">Figure 4B</xref>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 354 357 354 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
In addition, to characterize the progression of angle changes, two additional time points were added to this analysis of the iridocorneal angle -18 days and 4 weeks of age (n = 20 each). While at 18 days of age nearly half of the eyes demonstrated open angles, a large percentage already showed evidence of PAS (Figure 4B). By 4 weeks of age, Vav2-/-Vav3-/- mice showed increasing frequencies of both PAS and angle closure. Taken as a whole, the data showed a gradual progression from open angles to PAS formation to closed angle from 18 days to 12 weeks.
###end p 31
###begin p 32
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 178 181 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 174 181 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup></italic>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 284 298 284 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 305 314 305 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g004">Figure 4B</xref>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 321 324 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 415 424 415 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g004">Figure 4B</xref>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
The iridocorneal angles of Vav2-deficient (Vav2-/-) and Vav3-deficient (Vav3-/-) mice were examined histologically and graded in a similar manner. The iridocorneal angles of Vav2-/- mice also demonstrated evidence of progressive angle closure, but to a lesser extent as compared with Vav2-/-Vav3-/- mice (Figure 4B). Vav3-/- mice had normal appearing open angles without evidence of PAS formation or angle closure (Figure 4B).
###end p 32
###begin p 33
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 79 82 79 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Karali1">[17]</xref>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 225 228 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 339 348 339 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009050.s003">Figure S3</xref>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 409 412 409 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 416 419 416 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
In order to better investigate the status of iridocorneal angles in Vav2-/-Vav3-/- mice, we stained for myocilin as a marker for TM cells, as myocilin is strongly expressed in TM cells [17]. We examined 7-week-old Vav2-/-Vav3-/- mice with non-elevated IOP who had either open angles or who displayed evidence of angle closure. As shown in Figure S3, myocilin was not detected in the iridocorneal angle of Vav2-/-Vav3-/- mice with angle closure, but was seen in mice with open angles similar to those of wild-type mice.
###end p 33
###begin title 34
###xml 55 59 <span type="species:ncbi:10090">Mice</span>
Effects of Ocular Hypotensives in Vav2/Vav3 -Deficient Mice
###end title 34
###begin p 35
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 117 126 117 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009050.s004">Figure S4</xref>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 291 301 291 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009050.s004">Figure S4A</xref>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 350 353 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 357 360 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Weinreb1">[18]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Pfeiffer1">[20]</xref>
###xml 523 533 523 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009050.s004">Figure S4B</xref>
###xml 715 719 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Tanihara1">[21]</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Honjo1">[23]</xref>
###xml 776 780 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 780 783 780 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 783 787 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 867 877 867 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009050.s004">Figure S4C</xref>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 236 242 <span type="species:ncbi:9606">humans</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
We next tested the efficacy of ocular hypotensives used for human glaucoma in Vav2-/-Vav3-/- mice with elevated IOP (Figure S4). The elevated IOP of 7-week-old Vav2-/-Vav3-/- mice was dramatically reduced by ocular hypotensives used in humans, such as latanoprost, a prostaglandin analogue (Figure S4A). We also tested the IOP-lowering effect in Vav2-/-Vav3-/- mice by two other ocular hypotensives, dorzolamide and timolol, whose mechanisms of action differ from that of latanoprost [18]-[20], being aqueous suppressants (Figure S4B). Furthermore, we tested Y-27632, a Rho-associated protein kinase inhibitor, that has been reported to cause a reduction in IOP presumably by altering cellular behavior of TM cells [21]-[23]. Y-27632 showed no effect of lowering IOPs against Vav2-/-Vav3-/- mice, while it lowered the IOP significantly in age-matched wild-type mice (Figure S4C).
###end p 35
###begin title 36
###xml 31 36 <span type="species:ncbi:10090">Mouse</span>
###xml 41 46 <span type="species:ncbi:9606">Human</span>
Expression of Vav2 and Vav3 in Mouse and Human Eyes
###end title 36
###begin p 37
###xml 164 172 164 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g005">Figure 5</xref>
###xml 319 328 319 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g005">Figure 5A</xref>
###xml 551 554 551 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Bustelo1">[5]</xref>
###xml 556 559 556 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Turner1">[7]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Tybulewicz1">[16]</xref>
###xml 675 684 675 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g005">Figure 5B</xref>
###xml 958 967 958 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009050.s005">Figure S5</xref>
###xml 1310 1319 1310 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g005">Figure 5C</xref>
###xml 1623 1627 1623 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 1627 1630 1627 1630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1630 1634 1630 1634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 1634 1637 1634 1637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 611 616 <span type="species:ncbi:10090">mouse</span>
###xml 1288 1293 <span type="species:ncbi:10090">mouse</span>
###xml 1298 1303 <span type="species:ncbi:9606">human</span>
###xml 1325 1330 <span type="species:ncbi:10090">mouse</span>
###xml 1526 1531 <span type="species:ncbi:9606">human</span>
###xml 1638 1642 <span type="species:ncbi:10090">mice</span>
###xml 1833 1838 <span type="species:ncbi:10090">mouse</span>
###xml 1843 1848 <span type="species:ncbi:9606">human</span>
In order to understand the pathogenesis of the Vav2/Vav3-deficient eye phenotype, we examined the mRNA and protein expression patterns of Vav2 and Vav3 in the eye (Figure 5). Quantitative real-time PCR revealed that Vav2 and Vav3 mRNA are expressed in TM, cornea, retina, lens, iris, and ciliary body in the mouse eye (Figure 5A). Vav3 mRNA was more abundantly expressed than that of Vav2 in the TM and the retina. Gene expression levels of both Vav2 and Vav3 in the eye were comparable to levels found in immune cells where Vavs play a critical role [5], [7]-[16]. Next, the Vav2 and Vav3 mRNA localization in mouse eye was examined by in situ hybridization (ISH) analysis (Figure 5B). Both Vav2 and Vav3 oligo probes (antisense), we used here, have been examined the specificities before and proved to have its specificity. As negative controls for these experiments, we used sense probes of Vav2 and Vav3, respectively, which showed no detectable signal (Figure S5). Both genes expression were widely distributed in the ocular tissues including the iridocorneal angle, retina, cornea, and sclera. The co- localization of Vav2 and Vav3 mRNA expression in iridocorneal angle, such as TM, was confirmed by ISH. Also, we assessed Vav2 and Vav3 protein expression by immunoblotting in both mouse and human eyes (Figure 5C). In mouse eyes, expression of both Vav2 and Vav3 was demonstrated in several ocular tissues including the iridocorneal angle, retina, cornea, and sclera. Both Vav2 and Vav3 proteins were also expressed in human retina and iridocorneal angle. The migrated bands were absent in the liver extracts of the Vav2-/-Vav3-/- mice. Results of densitometric ratio (Vav3/Vav2) from normalized protein loading in each lane revealed that Vav3 was more abundantly expressed than Vav2 in the iridocorneal angle tissues of both mouse and human eyes and also in the retina.
###end p 37
###begin title 38
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
Vav2 and Vav3 expression in mouse and human eyes.
###end title 38
###begin p 39
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 248 250 248 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a.</bold>
###xml 391 393 391 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b.</bold>
###xml 594 599 594 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. a.</bold>
###xml 893 895 893 895 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b.</bold>
###xml 1038 1040 1034 1036 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 1088 1089 1084 1085 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 1102 1103 1098 1099 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 311 317 <span type="species:ncbi:10090">murine</span>
###xml 433 439 <span type="species:ncbi:10090">murine</span>
###xml 1081 1086 <span type="species:ncbi:10090">mouse</span>
###xml 1095 1100 <span type="species:ncbi:9606">human</span>
###xml 1151 1156 <span type="species:ncbi:10090">mouse</span>
###xml 1160 1165 <span type="species:ncbi:9606">human</span>
###xml 1367 1372 <span type="species:ncbi:10090">mouse</span>
###xml 1405 1410 <span type="species:ncbi:10090">mouse</span>
###xml 1449 1454 <span type="species:ncbi:10090">mouse</span>
###xml 1467 1472 <span type="species:ncbi:10090">mouse</span>
###xml 1485 1490 <span type="species:ncbi:10090">mouse</span>
###xml 1512 1517 <span type="species:ncbi:10090">mouse</span>
###xml 1567 1572 <span type="species:ncbi:10090">mouse</span>
###xml 1602 1607 <span type="species:ncbi:9606">human</span>
###xml 1639 1644 <span type="species:ncbi:9606">human</span>
###xml 1661 1666 <span type="species:ncbi:9606">human</span>
A. Quantitative real time PCR analysis is performed for Vav2 and Vav3 mRNA expression study. The vertical axis is the copy number of Vav2 or Vav3 mRNA when that of mGAPDH is taken as 1. The assay method is absolute quantification (standard curve). a. Both Vav2 and Vav3 mRNA are expressed in all tissues of the murine eyes including the trabecular meshwork (TM), cornea, sclera, and retina. b. Vav2 and Vav3 mRNA expression level of murine immune cells. The levels of Vav2 and Vav3 expression in eye tissues are the same as those of the immune cells where Vav2 and Vav3 play the critical role. B. a. In situ hybridization analysis of emulsion-dipped sections display the distribution of Vav2 and Vav3 mRNA in the anterior chamber. The localization of Vav2 and Vav3 mRNA in trabecular meshwork(TM), ciliary body (CB), cornia(CO), iris(Ir), sclera (Scl) and retina(Re) by in situ hybridization. b. Vav2 and Vav3 mRNA expression are both detected in iridocorneal angle, such as TM (indicated by arrows in the photos). Scale bars, 50 microm. C. Expression of Vav2 and Vav3 proteins in mouse (a) and human (b) eyes. Vav2 and Vav3 proteins were detected in mouse or human ocular extracts (from two independent postmortem eye globe samples; at death age of 58 (1) and 87 (2)) by western blotting. Densitometric ratios (Vav3/Vav2) were shown under the blotting panels. mICA: mouse iridocorneal angle tissues, mR: mouse retina, mR': 3-fold increased loading mouse retina, mC: mouse cornea, mS: mouse sclera, mLiv: normal mouse liver(positive control), KO: Vav2/Vav3-deficient mouse as a negative control, hICA: human iridocorneal angle tissue,hR1: human retina 1, hR1': human retina1' (3-fold loading).
###end p 39
###begin title 40
###xml 72 80 <span type="species:ncbi:9606">Patients</span>
Single Nucleotide Polymorphisms in Japanese Primary Open-Angle Glaucoma Patients
###end title 40
###begin p 41
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 580 587 580 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009050-t001">Table 1</xref>
###xml 649 653 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 692 696 692 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 698 702 698 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 933 935 933 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 946 947 946 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 272 277 <span type="species:ncbi:9606">Human</span>
###xml 445 453 <span type="species:ncbi:9606">patients</span>
We observed Vav2 and Vav3 proteins expression in the tissues of human iridocorneal angle and retina. In order to investigate the relevant association of VAV2 and VAV3 in human glaucoma patients, we carried out a genome-wide association study using the Affymetrix GeneChip Human Mapping 500 K Array Set. We examined Japanese primary open-angle glaucoma (POAG) cases and age-matched non-glaucoma controls. Both VAV2 and VAV3 loci in Japanese POAG patients showed SNPs against the non-glaucoma controls for dbSNPs rs2156323 and rs2801219, respectively. We reported the most extreme (Table 1). Both were intronic SNPs, SNP rs2156323 lying in intron3 of VAV2 and SNP rs2801219 lying in intron1 of VAV3. VAV2 SNP rs2156323 in particular indicated significant association with Japanese POAG, including a 5.65 heterozygote odds ratio (95% confidence interval (CI): 1.99-16.0), 4.34 heterozygote relative risk (95% CI: 1.72-10.44) and 4.38x10-4 genotypic P value with respect to risk allele A.
###end p 41
###begin title 42
Vav2, Vav3, Vav1 association study for POAG using the Affymetrix GeneChip.
###end title 42
###begin p 43
1: intronic S.
###end p 43
###begin p 44
###xml 21 22 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 180 182 180 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 244 252 244 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009050-g006">Figure 6</xref>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV1</italic>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 356 360 356 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
Judging from alleric P-values distribution for detecting VAV2 ranking and genotypic P- values distribution for VAV3 ranking, we observed that VAV2 and VAV3 showed high scores (-log10(P)) among approximately 380,000 SNPs analyzed in this study (Figure 6). On the contrary, VAV1 showed no association with the POAG. These data strongly suggest that VAV2 and VAV3 genes are susceptibility loci in Japanese POAG.
###end p 44
###begin title 45
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
VAV2 and VAV3 genome-wide SNPs high ranking of P-value scores.
###end title 45
###begin p 46
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 590 591 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 703 704 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 728 732 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 775 776 771 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 788 792 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 797 801 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV1</italic>
###xml 809 813 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 854 858 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 898 902 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV1</italic>
Genome-wide ranking orders of P-value indicate that VAV2 and VAV3 are strongly susceptible genes with Japanese POAG cases. Clinically diagnosed Japanese POAG 100 cases and non-glaucoma age-matched 100 controls are examined for this study. The analysed SNPs number is about 380,000 by the Affymetrix GeneChip 500 K Mapping Array Set. The SNPs data under the 85% call rate, under 0.001 Hardy-Weinberg equilibrium (HWE), and under 5% minor allele frequencies are excluded. Allelic frequency chi2 test and genotypic frequency chi2 test are calculated respectively. The vertical axis is -log10 (P) and the horizontal axis is SNPs order which showed high scores from left to right. The Upper graph is alleric P-values distribution of VAV2 analysis and the lower graph is genotypic P-values for VAV3 and VAV1 study. VAV2 is located at high position in rank and VAV3 also located at high position in rank. VAV1 shows no association for POAG cases here.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup></italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Pang1">[24]</xref>
###xml 764 767 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 771 774 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 760 774 760 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup>Vav3<sup>&#8722;/&#8722;</sup></italic>
###xml 801 804 801 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 797 804 797 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2<sup>&#8722;/&#8722;</sup></italic>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
To our knowledge, this is the first report of a spontaneous glaucoma phenotype in Vav2 (Vav2-/-) or Vav2/Vav3-deficient (Vav2-/-Vav3-/-) mice. Vav2/Vav3-deficiency is associated with progressive iridocorneal angle changes and elevation of IOP in mice. Subsequent selective loss of RGCs and progressive ONH cupping are associated with this elevated IOP, as has previously been demonstrated in other rodent models of glaucoma [24]. The finding that Vav2-deficiency alone results in a glaucoma phenotype suggests that the absence of Vav2 plays a critical role in the development of this phenotype. Despite our finding that Vav3-deficiency did not result in either iridocorneal angle changes or elevated IOP, the more severe glaucomatous phenotype demonstrated in Vav2-/-Vav3-/- mice as compared with Vav2-/- mice is consistent with an additive effect.
###end p 48
###begin p 49
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Pang1">[24]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Aihara1">[25]</xref>
###xml 61 65 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 320 325 <span type="species:ncbi:10090">mouse</span>
###xml 381 385 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
###xml 452 457 <span type="species:ncbi:10090">mouse</span>
###xml 511 516 <span type="species:ncbi:9606">human</span>
###xml 606 612 <span type="species:ncbi:9606">humans</span>
A number of induced glaucoma models have been established in rats and mice [24]. Each model has advantages and disadvantages, related to factors such as the ease of inducing elevated IOP, the magnitude, duration and variability of elevated IOP, and secondary effects on the eye. Due to the ease of genetic manipulation, mouse models are becoming increasingly popular over those in rats. Despite the lack of a lamina cribosa as found in human eyes, the mouse is a good genetic model to study the pathogenesis of human glaucoma as aqueous physiology and anterior segment anatomy are similar to that found in humans [25].
###end p 49
###begin p 50
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Chang1">[26]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Schlamp1">[29]</xref>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gpnmb</italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyrp1</italic>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Chang1">[26]</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Anderson1">[30]</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 804 809 <span type="species:ncbi:9606">human</span>
Other spontaneous models of glaucoma have been described in mice, most notably in DBA/2J mice. The pigmentary glaucoma phenotype demonstrated in the DBA/2J mice has been extensively studied at genetic, clinical, morphological and pathological levels [26]-[29]. A limitation of this model is that the elevated IOP phenotype is not primary but secondary due to the systemic pigment dispersion syndrome with the associated mutations in the Gpnmb and Tyrp1 loci [26]-[30]. In these mice, recessive mutations in these 2 genes are associated with iris degeneration characterized by iris stromal atrophy and pigment dispersion with subsequent reduced outflow facility secondary to pigment and cell debris. Therefore, it is difficult to tie-in the identified mutations to the pathogenesis of any primary form of human glaucoma.
###end p 50
###begin p 51
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 417 422 <span type="species:ncbi:9606">human</span>
###xml 516 521 <span type="species:ncbi:10090">mouse</span>
The Vav2/Vav3-deficient mouse has several characteristics which make it particularly useful as an animal glaucoma model. The elevated IOP occurs spontaneously in these genetically manipulated mice and does not require the ocular manipulation necessary in induced models. The frequency of the ocular phenotype is high and onset occurs at a relatively young age. In addition, ocular hypotensives commonly used to treat human glaucoma show efficacy in lowering IOP in this model. The most significant advantage of this mouse glaucoma model is that the deleted genes, Vav2 and Vav3, are well-focused targets that have been studied over 20 years providing a useful starting point for further investigation of the potential molecular mechanisms underlying this phenotype.
###end p 51
###begin p 52
###xml 382 386 <span type="species:ncbi:10090">mice</span>
Several aspects of this model of spontaneous glaucoma will require further study and clarification, although we speculated from our histological results and the correlation between elevated IOP and angle status changes that anatomic angle closure is the possible mechanism for elevated IOP in this model. While progressive angle closure may be the etiology prior to elevated IOP in mice lacking Vav2 and Vav3 function, it may alternatively be a subsequent change related to other alterations in angle structures which might also affect aqueous humor outflow. In addition, since the expression of Vav2 and Vav3 was detected in ocular tissues other than those comprising the iridocorneal angle, it will be necessary in future studies to consider how their deficiency in these tissues might have potentially contributed to the spontaneous glaucoma phenotype in any way.
###end p 52
###begin p 53
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Nakano1">[31]</xref>
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Ishikawa1">[36]</xref>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Jiao1">[37]</xref>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Kumar1">[43]</xref>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
While so far there are several reports of glaucoma associated candidate genes based on the single nucleotide polymorphisms (SNPs) study in the Japanese population [31]-[36], our data first suggest that VAV2 and VAV3 are susceptibility loci in Japanese primary open-angle glaucoma (POAG) cases. In addition, so far we could not find the report of non-Japanese glaucoma association case study that demonstrated VAV2 and/or VAV3 as candidate gene loci for glaucoma [37]-[43]. They demonstrated glaucoma associated candidate genes study with SNPs analysis focusing on the other specific target genes, although we are interested in the VAV2 and/or VAV3 glaucoma association study using the different populations. This work would be important investigation to be done.
###end p 53
###begin p 54
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Bill1">[44]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Wiedelholt1">[45]</xref>
###xml 681 684 681 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Tan1">[4]</xref>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Filla1">[46]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Diskin1">[48]</xref>
###xml 367 372 <span type="species:ncbi:9606">human</span>
Although our current findings do not address the molecular mechanisms underlying glaucoma phenotypes, it is interesting to consider possible mechanisms based on what is currently known about Vav protein function. The TM has been regarded as a key determinant of IOP and has been implicated as the major site of increased resistance to aqueous outflow which occurs in human glaucoma [44], [45]. Recent findings indicate that signals emanating from integrins, key regulators of the actin cytoskeleton in trabecular meshwork cells, may be involved in control of outflow facility and Rho GTPases would be important downstream effectors of integrin-mediated actin cytoskeletal dynamics [4], [46]-[48]. Considering the Vavs function as GEF, dysregulation of Rho is one possible mechanism by which pathology in the iridocorneal angle might result and is one that deserves further study.
###end p 54
###begin p 55
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 309 315 <span type="species:ncbi:10090">murine</span>
###xml 436 442 <span type="species:ncbi:9606">humans</span>
In summary, we had demonstrated that Vav2/Vav3-deicient mice develop a spontaneous glaucoma phenotype. In addition, our data first suggest that VAV2 and VAV3 are susceptibility loci in Japanese primary open-angle glaucoma (POAG) cases. We believe that Vav2/Vav3-deficient mice will serve not only as a useful murine model of spontaneous glaucoma, but may also provide a valuable tool in understanding of the pathogenesis of glaucoma in humans, particularly the determinants of altered aqueous outflow and elevated IOP.
###end p 55
###begin title 56
Materials and Methods
###end title 56
###begin title 57
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 57
###begin p 58
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Fujikawa1">[15]</xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">Mice</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
Vav3-/-, Vav2-/- and Vav2-/-Vav3-/- mice were described previously [15]. Mice were backcrossed at least 9 times with C57BL/6 mice (Clea Japan, Tokyo, Japan) to have the C57BL/6 background. All mice used in these experiments were bred and maintained in the SPF Facility of Hokkaido University Graduate School of Medicine in a 12-hour light-dark cycle. All mice experiments were approved by the Animal Ethics Committee of Hokkaido University Graduate School of Medicine and were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
###end p 58
###begin title 59
Tissue Preparation and Histology
###end title 59
###begin p 60
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Eyes were quickly enucleated from each age group of knock-out mice and C57BL/6 wild-type control mice after deep anesthesia with pentobarbital sodium solution, then immediately fixed with solution of 2.5% glutaraldehyde (TAAB, EM Grade) in 10% formalin neutral buffer-methanol solution deodorized for anterior chamber study, or fixed with Davidson' solution for retinal analysis for 12 hours. Following this, the eyes were embedded in paraffin and dissected sagittally using a microtome into 5 microm sections. After deparaffinization and rehydration, the sections were stained with hematoxylin and eosin (Sigma).
###end p 60
###begin title 61
Immunohistochemistry
###end title 61
###begin p 62
###xml 284 290 <span type="species:ncbi:9986">rabbit</span>
###xml 408 414 <span type="species:ncbi:9986">rabbit</span>
The eyes were sectioned at 5 microm thickness along the vertical meridian through the optic nerve head. After deparaffinization and rehydration, the tissue sections were incubated with blocking solution containing 1% BSA in PBS for 1 hour. This was followed by 1 hour incubation with rabbit polyclonal antibody to myocilin at 1:200 in blocking solution as first antibody for 1 hour at room temperature. Anti-rabbit IgG conjugated with Alexa 488 (Molecular Probes, Eugene, OR) at 1:400 in PBS containing 0.1% Tween 20 was used as secondary antibody for 1 hour at room temperature. The stained tissues were examined using confocal fluorescence laser microscope (Radius 2000, Bio-Rad, Hercules, CA). For negative control of the immunohistochemical staining, the sections were incubated with blocking solution without primary antibody (data not shown).
###end p 62
###begin title 63
Real Time PCR
###end title 63
###begin p 64
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 178 181 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
Each tissue was freshly taken from SPF level C57BL/6 mice and immediately used for generating RNA by TRIzol reagent (Invitrogen). Templates for real time PCR were made by Cloned AMV Reverse Transcriptase (Invitrogen). Probes of mVav2 and mVav3 were TaqMan probes (Vav2: Mm00437287_m1, Vav3: Mm00445082_m1) purchased from Applied Biosystems (Foster city, CA). The standard curves were constructed by mVav2, mVav3 inserted plasmids, normalized by mGAPDH (Product Code: 4352339E, Applied Biosystems). All the PCR studies were performed by Applied Biosystems 7500 Real Time PCR System following the manufacturer's recommended procedures. The assay method was absolute quantification (standard curve).
###end p 64
###begin title 65
In Situ Hybridization
###end title 65
###begin p 66
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009050-Fukaya1">[49]</xref>
###xml 188 240 188 240 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCTGGAGACCGGCTTGAGGCC CTGCTGGTGGTTCGCTCCCGAGA-3&#8242;</named-content>
###xml 311 363 311 363 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8211;GTTGCCTGTTCTATTACCCCTCTG TCCAGCTGGCTGTTCTGGCTC-3&#8242;</named-content>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
The detailed procedure was described as previously [49]. Briefly, to detect mRNAs for Vav2 and Vav3, specific antisense oligonucleotide probes were synthesizedas follows:(2275-2319;45mers)5'-AGCTGGAGACCGGCTTGAGGCC CTGCTGGTGGTTCGCTCCCGAGA-3' for Vav2 mRNA (GenBank accession No. NM_009500) and (2346-2302;45mers)5'-GTTGCCTGTTCTATTACCCCTCTG TCCAGCTGGCTGTTCTGGCTC-3' for Vav3 mRNA (accession No. NM_020505). Oligonucleotide probes were labeled with [33P] dATP using terminal deoxyribonucleotidyl transferase (Invitrogen, Carlsbad, CA). Under deep pentobarbital anesthesia, the eyeballs were freshly obtained from Adult C57BL/6J mice. Fresh frozen sections (20 microm thickness) were cut with a cryostat (CM1900, Leica, Nussloch,Germany) and mounted on glass slides precoated with 3-aminopropyltriethoxysilane. Sections were exposed to Nuclear Track emulsion (NTB-2, Kodak) for 5 weeks. Emulsion-dipped sections were stained with methyl green pyronine solution. The specificity of the hybridizing signals was verified by the disappearance of signals when hybridization was carried out with sense probes.
###end p 66
###begin title 67
Western Blotting
###end title 67
###begin p 68
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 358 363 <span type="species:ncbi:9606">Human</span>
###xml 376 381 <span type="species:ncbi:9606">Human</span>
###xml 483 488 <span type="species:ncbi:9689">Lions</span>
###xml 552 557 <span type="species:ncbi:10090">mouse</span>
###xml 573 578 <span type="species:ncbi:9606">human</span>
###xml 746 752 <span type="species:ncbi:9986">Rabbit</span>
###xml 769 774 <span type="species:ncbi:10090">mouse</span>
###xml 837 842 <span type="species:ncbi:9606">human</span>
###xml 906 911 <span type="species:ncbi:10090">mouse</span>
###xml 921 926 <span type="species:ncbi:9606">human</span>
Mouse Ocular Tissue Dissection: 8-week male C57BL/6J mice (Jackson Laboratory, ME) were used for ocular tissue samples. The animals were euthanized by carbon dioxide inhalation in an induction chamber. The globes were promptly enucleated after euthanization and washed in ice-cold PBS. Ocular tissues were microscopically dissected. Dissection of Postmortem Human Eye Globes: Human eyes without previous eye diseases including glaucoma were acquired from a local eye bank (Heartland Lions Eye Banks; Columbia, MO) within 6 hours post-mortem. Dissected mouse and postmortem human ocular tissues were lysed in a tissue extraction buffer (BioChain, CA). The concentration of protein supernatants was determined by a protein assay kit (Bio-Rad, CA). Rabbit polyclonal anti-mouse Vav2 (1:1000) (Santa Cruz Biotechnology, CA), monoclonal anti-human Vav2 (1:2000) (Cell Signaling Technology, MA), polyclonal anti-mouse and anti-human Vav3 (1:3000 for each) (Millipore, CA) antibodies were used for detection.
###end p 68
###begin title 69
Intraocular Pressure (IOP) Measurement
###end title 69
###begin p 70
###xml 229 233 <span type="species:ncbi:10090">Mice</span>
IOP was measured using the TonoLab rebound tonometer for rodents (Tiolat i-care, Finland) according to the manufacturer's recommended procedures. All IOP measurements were performed between 10 AM and noon in conscious condition. Mice were gently restrained first by hand and placed on a soft towel bed on the desk and usually appeared calm and comfortable. These data were confirmed to be reproducible by three additional different independent studies (n = 20).
###end p 70
###begin title 71
###xml 88 92 <span type="species:ncbi:10090">Mice</span>
Evaluation of Eye Drop Medications for High Intra-Ocular Pressure of Vav2Vav3-Deficient Mice
###end title 71
###begin p 72
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Vav2-/-Vav3-/- mice were housed in SPF barrier facility in standard lighting conditions (12-hour light-dark cycle). The 7-9 week after birth mice were used for the experiment. Four independent experiments were carried out to confirm the results reproducible.
###end p 72
###begin title 73
Preparation and Application of Ophthalmic Solution
###end title 73
###begin p 74
###xml 382 386 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav2</italic>
###xml 386 389 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 389 393 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav3</italic>
###xml 393 396 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
Latanoprost was purchased from Cayman Chemical Co. (Ann Arbor, MI) and dissolved in its vehicle solution (0.02% benzalkonium chloride, 0.5% monosodium phosphate monohydrate, 0.6% disodium hydrogen phosphate dihydrate and 0.4% sodium chloride). With a micropipette, 3 microl of PG analogue (latanoprost; prostaglandin F2alpha) solution or vehicle was randomly applied to the eyes of Vav2-/-Vav3-/- mice. Before administration, IOP was measured with the tonometer from 10-12 AM and then the PG analogue 0.005% 3 microl or vehicle solution was applied in a masked manner. Evaluation of IOP-lowering effect was performed by measuring the IOP with the tonometer at 3 hours after drug instillation also in a masked manner. Furthermore, two different mechanistic medications, 3 microl of timolol maleate (0.5%, Merck, Whitehouse Station, NJ) or 3 microl of dorzolamide hydrochloride (1%, Trusopt; Merck), was also tested, respectively, after measuring the IOP under the same conditions as those of the Latanoprost application. Evaluation of IOP-lowering effects was performed by measuring the IOP with tonometer at 2 hours after drug instillation under blinded test protocols. Y-27632 was purchased from Carbiochem (La Jolla, CA) and dissolved in its vehicle solution (phosphate buffered saline). Y-27632 (1 mM) or vehicle solution was administered to the central cornea as a 3 microl drop by pipetting in a masked manner. Evaluation of IOP-lowering effect was performed by measuring the IOP with the tonometer at 1 hour after drug instillation.
###end p 74
###begin title 75
Statistical Analysis of IOPs
###end title 75
###begin p 76
Data are reported as means +/- S.D. Two-tailed Student's t-test was used to compare between two groups of results. Differences between any two groups were regarded as significant when P<0.01(**) or P<0.05 (*).
###end p 76
###begin title 77
Disease Associated Genome-Wide Analysis
###end title 77
###begin p 78
###xml 913 914 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 947 948 943 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1294 1298 1290 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV2</italic>
###xml 1300 1304 1296 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV3</italic>
###xml 1310 1314 1306 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VAV1</italic>
###xml 327 339 <span type="species:ncbi:9606">participants</span>
###xml 597 602 <span type="species:ncbi:9606">Human</span>
One hundred clinically-diagnosed cases (male 46; female 54) with primary open-angle glaucoma over 30 years of age (mean age, 71.60 years; SD, 9.33 years) and non-glaucoma age-matched controls (mean age, 66.71 years; SD, 12.00 years) in a Japanese population were examined for this study. Informed consent was obtained from all participants, and the procedures used conformed to the tenets of the Declaration of Helsinki. Genomic DNAs were isolated from the peripheral blood of the POAG cases and age-matched controls for genotyping analysis. Genotyping was performed using the Affymetrix GeneChip Human Mapping 500 K Array Set (Affymetrix Services Laboratory, California). We omitted the SNP data under an 85% call rate, under 0.001 Hardy-Weinberg equilibrium (HWE), and under 5% minor allele frequency. Data analysis was performed using the LaboServer System (World Fusion, Tokyo Japan). An allelic frequency chi2 test and genotypic frequency chi2 test were calculated, respectively with respect to risk allele. The Odds ratio was calculated in three manners such as per allele odds ratio, heterozygote odds ratio, and homozygote odds ratio. Relative risk was also calculated, the same as for the odds ratio. The most significant SNPs were chosen in this report to evaluate the association of VAV2, VAV3, and VAV1 in the cases.
###end p 78
###begin title 79
Supporting Information
###end title 79
###begin p 80
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
The comparison of intraocular pressures in age matched wild-type inbred C57BL/6 mice, wild-type littermate controls, and Vav2 and Vav3 heterozygous mice (Vav2+/-, and Vav3+/-). Intraocular pressures (IOPs) were measured using the TonoLab rebound tonometer for rodents from 6-week to 12-week, as described in the Methods. The phenotype of littermate wild-type mice was identical to that of the "inbred" C57BL/6 strain. The phenotype of Vav2 and Vav3 heterozygous mice were similar to that of wild-type. n = 20.
###end p 80
###begin p 81
(0.45 MB TIF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 239 242 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 246 249 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
The correlation between elevated IOP and angle changes in Vav2/Vav3-deficient mice. The IOP was measured in 7-week-old Vav2/Vav3-deficient (Vav2-/-Vav3-/-) mice (n = 20), followed by examination of the angle status by histology. While Vav2-/-Vav3-/- mice with elevated IOP displayed histological evidence of angle closure, mice without elevated IOP showed either normal open angles or evidence of angle changes, angle closure or peripheral anterior synechiae. The mean and standard deviation of IOP in wild-type mice at 7-week-old (n = 18) were 13.7+/-3.12 mmHg, respectively. The 95th percentile of those IOPs using a normal curve was 18.8 mmHg. IOP over 18.8 mmHg was regarded here as elevated IOP.
###end p 83
###begin p 84
(0.57 MB TIF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 255 258 255 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 262 265 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 501 504 501 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 508 511 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
Anti-myocilin staining of trabecular meshwork in Vav2/Vav3-deficient mice. Immunohistochemical staining of trabecular meshwork with anti-myocilin antibody in representative iridocorneal angle sections of age-matched wild-type and Vav2/Vav3-deficient (Vav2-/-Vav3-/-) 7-week-old mice with normal IOP, with either evidence of angle closure, or normal open angles similar to wild type mice. Myocilin (green-labeled), which is strongly expressed in TM cells, was regarded as a marker for TM cells. In Vav2-/-Vav3-/- mice with angle closure, myocilin was not detected in the iridocorneal angle (indicated by arrows). Conversely, it was detected in sections from mice with normal open angles, similar to those in wild type mice. Blue fluorescence is DAPI counter staining. Scale bars, 20 um.
###end p 86
###begin p 87
(2.19 MB TIF)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
###xml 196 199 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 440 443 436 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 447 450 443 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 606 609 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 613 616 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 811 814 803 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 818 821 810 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1094 1097 1086 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1101 1104 1093 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1198 1201 1190 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1205 1208 1197 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1272 1275 1264 1267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1279 1282 1271 1274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 1105 1109 <span type="species:ncbi:10090">mice</span>
###xml 1209 1213 <span type="species:ncbi:10090">mice</span>
###xml 1283 1287 <span type="species:ncbi:10090">mice</span>
###xml 1420 1424 <span type="species:ncbi:10090">mice</span>
###xml 1731 1735 <span type="species:ncbi:10090">mice</span>
Effects of ocular hypotensives in Vav2/Vav3-deficient mice. A. Ocular hypotensives used for human glaucoma, latanoprost, a prostaglandin analogue was tested in 7-week-old Vav2/Vav3-deficient (Vav2-/-Vav3-/-) mice with elevated IOP (n = 20). The IOP was measured 3 hours before and after topical application of 3 microl of 0.01% latanoprost in a masked manner. Vehicle was used as a control. Latanoprost lowered the IOP significantly in Vav2-/-Vav3-/- mice (26.3+/-5.0 mmHg versus 15.8+/-5.1 mmHg; n = 20), while the IOP was not altered by the vehicle alone. The latanoprost-induced reduction of IOP in Vav2-/-Vav3-/-mice was statistically significant (**P<0.01, n = 20). The data shown are representative of three independent experiments performed. Error bars represent S.D. **P<0.01 versus vehicle-treated Vav2-/-Vav3-/- mice. B. Using three different drugs for lowering IOP, we compared the effects by percentages of elevated IOP reduction. These data are representative from three independent experiments, respectively (n = 20). Error bars represent S.D. **P<0.01 versus vehicle-treated Vav2-/-Vav3-/- mice. C. Rho-associated protein kinase Inhibitor, Y-27632 was tested for lowering IOP on Vav2-/-Vav3-/- mice (n = 20). Y27632 administration has no effect against Vav2-/-Vav3-/- mice (before, 19.69+/-4.98 mmHg; after, 18.83+/-5.60 mmHg; n = 20), while Y-27632 lowered the IOP significantly in age-matched wild-type mice (13.58+/-2.27 mmHg versus 12.31+/-1.94 mmHg; n = 20. p<0.05) and the IOP was not altered by the vehicle solution (13.25+/-1.71 mmHg versus 13.18+/-3.17 mmHg; n = 20). These data are representative from four independent experiments, respectively. Error bars represent S.D. *P<0.05 versus vehicle-treated WT mice.
###end p 89
###begin p 90
(0.41 MB TIF)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 348 353 <span type="species:ncbi:10090">mouse</span>
Sense probe staining for in situ hybridization experiments in ocular tissues. In situ hybridization with Vav2 and Vav3 sense probes were carried out as negative controls for the experiments. C57BL/6 mouse ocular tissue sections including the iridocorneal angle, sclera and cornea were used. With sense probes, there was no detectable signal around mouse iridocorneal angle tissues. TM; trabecular meshwork. Scl; sclera.
###end p 92
###begin p 93
(4.14 MB TIF)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
The authors thank Professor Duco Hamasaki (Bascom Palmer Eye Institute, University of Miami School of Medicine, Florida) and Morton Smith, M.D. (Washington University Department of Ophthalmology & Visual Sciences) for helpful suggestions and discussion; and Mr. Tsutomu Osanai and Ms. Takae Oyama for technical help.
###end p 95
###begin title 96
References
###end title 96
###begin article-title 97
The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
###end article-title 97
###begin article-title 98
The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.
###end article-title 98
###begin article-title 99
Changes in aqueous humor dynamics with age and glaucoma.
###end article-title 99
###begin article-title 100
Recent developments in understanding the pathophysiology of elevated intraocular pressure.
###end article-title 100
###begin article-title 101
Vav protein, adaptors and cell signaling.
###end article-title 101
###begin article-title 102
Guanine nucleotide exchange factors for Rho GTPases: turning on the switch.
###end article-title 102
###begin article-title 103
VAV proteins as signal integrators for multi-subunit immune-recognition receptors.
###end article-title 103
###begin article-title 104
The Vav family: at the crossroads of signaling pathways.
###end article-title 104
###begin article-title 105
Vav1 phosphorylation is induced bybeta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization.
###end article-title 105
###begin article-title 106
Vav GEFs are required for beta2 integrin-dependent functions of neutrophils.
###end article-title 106
###begin article-title 107
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction.
###end article-title 107
###begin article-title 108
Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity.
###end article-title 108
###begin article-title 109
Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation.
###end article-title 109
###begin article-title 110
Vav3 regulates osteoclast function and bone mass.
###end article-title 110
###begin article-title 111
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.
###end article-title 111
###begin article-title 112
Vav1: a key signal transducer downstream of the TCR.
###end article-title 112
###begin article-title 113
###xml 94 99 <span type="species:ncbi:9606">human</span>
Localization of myocilin/trabecular meshwork-inducible glucocorticoid response protein in the human eye.
###end article-title 113
###begin article-title 114
Effects of prostaglandins on the aqueous humor outflow pathways.
###end article-title 114
###begin article-title 115
Experimental studies on the mechanism of action of timolol.
###end article-title 115
###begin article-title 116
Dorzolamide: Development and clinical application of a topical carbonic anhydrase inhibitor.
###end article-title 116
###begin article-title 117
Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers.
###end article-title 117
###begin article-title 118
Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork.
###end article-title 118
###begin article-title 119
Effects of Rho-associated protein kinase inhibitor, Y-27632, on intraocular pressure and outflow facility.
###end article-title 119
###begin article-title 120
Rodent models for glaucoma retinopathy and optic neuropathy.
###end article-title 120
###begin article-title 121
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Aqueous humor dynamics in mice.
###end article-title 121
###begin article-title 122
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice.
###end article-title 122
###begin article-title 123
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.
###end article-title 123
###begin article-title 124
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas.
###end article-title 124
###begin article-title 125
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Progressive ganglion cells loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric.
###end article-title 125
###begin article-title 126
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Mutations in genes encoding melanosomal proteins cuase pigmentary glaucoma in DBA/2J mice.
###end article-title 126
###begin article-title 127
Three susceptible loci associated with primary open-angle glaucoma identified by genome-wide association study in a Japanese population.
###end article-title 127
###begin article-title 128
###xml 35 43 <span type="species:ncbi:9606">patients</span>
LOXL1 variants in elderly Japanese patients with exfoliation syndrome/glaucoma, primary open-angle glaucoma, normal tension glaucoma, and cataract.
###end article-title 128
###begin article-title 129
Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma.
###end article-title 129
###begin article-title 130
###xml 86 94 <span type="species:ncbi:9606">patients</span>
SNPs and interaction analyses of noelin 2, myocilin, and optineurin genes in Japanese patients with open-angle glaucoma.
###end article-title 130
###begin article-title 131
Polymorphism of b-adrenergic receptors and susceptibility to open-angle glaucoma.
###end article-title 131
###begin article-title 132
Association between glaucoma and gene polymorphism of endothelin type A receptor.
###end article-title 132
###begin article-title 133
Common variants on chromosome 2 and risk of primary open-angle glaucoma in the Afro-Caribbean population of Barbados.
###end article-title 133
###begin article-title 134
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Evaluation of nine candidate genes in patients with normal tension glaucoma: a case control study.
###end article-title 134
###begin article-title 135
Loss of function mutations in the gene encoding latent transforming growth factor beta binding protein 2, LTBP2, cause primary congenital glaucoma.
###end article-title 135
###begin article-title 136
Fine mapping of the GLC1K juvenile primary open-angle glaucoma locus and exclusion of candidate genes.
###end article-title 136
###begin article-title 137
Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations.
###end article-title 137
###begin article-title 138
Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
###end article-title 138
###begin article-title 139
###xml 130 138 <span type="species:ncbi:9606">patients</span>
Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients.
###end article-title 139
###begin article-title 140
###xml 165 168 <span type="species:ncbi:9606">man</span>
Scanning electron microscopic studies of the trabecular meshwork and the canal of Schlemm: an attempt to localize the main resistance to outflow of aqueous humor in man.
###end article-title 140
###begin article-title 141
###xml 82 88 <span type="species:ncbi:9913">bovine</span>
Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye.
###end article-title 141
###begin article-title 142
###xml 99 104 <span type="species:ncbi:9606">human</span>
Beta1 and beta3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells.
###end article-title 142
###begin article-title 143
Heparin II domain of fibronectin uses alpha4beta1 integrin to control focal adhesion and stress fiber formation, independent of syndecan-4.
###end article-title 143
###begin article-title 144
The role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading.
###end article-title 144
###begin article-title 145
NR2 to NR3B subnit switchover of NMDA receptors in early postnatal motoneurons.
###end article-title 145
###begin p 146
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 146
###begin p 147
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The work described in this report was funded in parts by a grant from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 147

